MCHIP is the USAID Bureau for Global Health’s flagship maternal , neonatal and child health (MNCH) program, which focuses on reducing maternal, neonatal and child mortality and accelerating progress toward achieving Millennium Development Goals (MDGs) 4 and 5. Awarded to Jhpiego and partners in September 2008, MCHIP works with USAID missions, governments, nongovernmental organizations, local communities and partner agencies in over 50 developing countries to implement programs at scale for sustainable improvements in MNCH.
USAID’s strategic approach for advancing maternal and child health identifies 30 “priority countries” – which account for more than 70% of the world’s maternal, newborn and child deaths—with documented magnitude and severity of need; established presence of USAID in health; and ability to implement expanded MNCH programming and achieve mortality reductions. MCHIP supports this approach by addressing the barriers to accessing and using focused, evidence-based interventions along the MNCH continuum of care from pre-pregnancy to age five, and by linking communities, first-level facilities, and hospitals. MCHIP will promote and support the integration of family planning, malaria, and HIV/AIDS activities within MNCH programs as appropriate.
Under this Leader with Associates Award (LWA), USAID Missions and Regional Bureaus can access the project through traditional field support and MAARD mechanisms to the Leader award, or through stand-alone Associate Awards. In addition to the MNCH priority countries, MCHIP can work in any country with Mission or regional Bureau funds.